IGC Pharma (IGC) Deferred Taxes (2010 - 2016)

IGC Pharma (IGC) has reported Deferred Taxes for 7 consecutive years, with $579.0 the latest figure, recorded in Q1 2016.

• On a quarterly basis, Deferred Taxes fell 81.49% year-over-year to $579.0 in Q1 2016; TTM through Mar 2016 was $3707.0, a 18.51% increase from a year earlier, with the FY2017 full-year figure at $18968.0, up 3175.99% from the prior year.
• Deferred Taxes was $579.0 for Q1 2016 at IGC Pharma, down from $3128.0 in the prior quarter.
• Over five years, Deferred Taxes peaked at $863953.0 in Q1 2012 and troughed at -$522498.0 in Q1 2013.
• A 5-year average of $33176.5 and a median of $1596.0 in 2013 frame the typical range for Deferred Taxes.
• The widest YoY moves for Deferred Taxes: up 278.51% in 2013, down 160.48% in 2013.
• Over 5 years, Deferred Taxes stood at $498.0 in 2012, then surged by 278.51% to $1885.0 in 2013, then jumped by 684.67% to $14791.0 in 2014, then plunged by 78.85% to $3128.0 in 2015, then plunged by 81.49% to $579.0 in 2016.
• The last three Deferred Taxes figures came in at $579.0 (Q1 2016), $3128.0 (Q1 2015), and $14791.0 (Q1 2014), per Business Quant data.